Townsend, R.R. Mahfoud, F. Kandzari, D.E. Kario, K. Pocock, S. Weber, M.A. Ewen, S. Tsioufis, K. Tousoulis, D. Sharp, A.S.P. Watkinson, A.F. Schmieder, R.E. Schmid, A. Choi, J.W. East, C. Walton, A. Hopper, I. Cohen, D.L. Wilensky, R. Lee, D.P. Ma, A. Devireddy, C.M. Lea, J.P. Lurz, P.C. Fengler, K. Davies, J. Chapman, N. Cohen, S.A. DeBruin, V. Fahy, M. Jones, D.E. Rothman, M. Böhm, M. Aoki, J. Batson, B. Dangas, G. David, S. Patel, M. Patel, K. Singh, J. Weber, T. Weil, J. Zeller, T. Ziada, K. Tanabe, K. Wilkins, R. Contreras, J. Steigerwalt, S. Reedus, D. Hoshide, S. Svetkey, L. Rao, A. Brown, A. Suppan, M. Agdirlioglu, T. Noory, E. Chasen, C. SPYRAL HTN-OFF MED trial investigators* SPYRAL HTN-OFF MED trial investigators*, Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial, The Lancet Neurology, (390), 2160-2170, 2017, The Lancet Publishing Group,